In a monumental achievement for global health, the World Health Organization (WHO) has officially validated Algeria as having eliminated trachoma as a public health problem. This landmark announcement marks Algeria as the 10th country in the WHO African Region and the 29th globally to conquer the world’s leading infectious cause of blindness. This victory is not merely a statistical milestone; it is the culmination of over a century of dedicated scientific research, political persistence, and a steadfast commitment to universal healthcare.
Understanding the Enemy: The Nature of Trachoma
Trachoma is a devastating, preventable disease caused by the bacterium Chlamydia trachomatis. It is primarily transmitted through direct contact with infected eye discharge, often spread by hands, clothing, or the presence of flies in environments with poor sanitation.
When left untreated, the disease is insidious. Repeated infections trigger chronic inflammation of the inner upper eyelid, leading to scarring. This scarring causes the eyelid to turn inward—a painful condition known as trachomatous trichiasis (TT)—where the eyelashes constantly scratch the eyeball. Without corrective surgery, this eventually leads to permanent visual impairment or total blindness.
Globally, the scale of the crisis remains significant: 97 million people live in endemic areas, and approximately 1.9 million people suffer from visual impairment or blindness due to this disease. For decades, it was a silent epidemic that trapped millions in cycles of poverty and suffering. Today, Algeria’s success provides a blueprint for the 30 countries where the disease remains endemic.
A Century of Persistence: The Chronology of Success
Algeria’s journey to elimination is a testament to the power of long-term strategic planning. The nation’s engagement with the disease dates back to 1909 with the establishment of the Pasteur Institute of Algeria. However, the modern era of the fight against trachoma truly gained momentum following the country’s independence.
The Foundation (1960s–1970s)
Post-independence, Algerian physicians, spearheaded by the visionary Professor Mohamed Aouchiche, recognized that trachoma was a public health crisis that required a national response. In 1974, the government launched a massive overhaul of the public healthcare system, ensuring that services—including specialized eye care—were provided free of charge. This decision removed the primary barrier to treatment: cost.
The Strategic Shift (2013–2015)
To accelerate the final push toward elimination, the Algerian government implemented a rigorous three-year strategy between 2013 and 2015. A National Expert Committee was formed to coordinate efforts, specifically targeting 12 southern provinces—including Adrar, Tamanrasset, and Ghardaïa—where the disease had historically maintained a foothold.
Final Verification (2022–2025)
In 2022, the government conducted extensive WHO-compliant surveys across the country. While the results confirmed the elimination threshold for active trachoma was met, three areas showed persistent challenges regarding trachomatous trichiasis (TT). Rather than resting on their laurels, health authorities launched a targeted, door-to-door screening and surgical campaign to address those specific pockets. By December 2025, the Ministry of Health submitted a comprehensive dossier of evidence to the WHO, confirming that the country had officially met all criteria for elimination.
The SAFE Strategy: A Multidisciplinary Approach
Algeria’s success was rooted in the implementation of the WHO-recommended "SAFE" strategy, a comprehensive framework that addresses both the medical and social determinants of the disease:
- S (Surgery): Providing corrective surgical procedures for patients with late-stage trachomatous trichiasis to prevent further damage to the eye.
- A (Antibiotics): Utilizing mass administration of antibiotic treatments to clear the Chlamydia trachomatis infection from populations at risk.
- F (Facial Cleanliness): Launching nationwide public awareness campaigns to emphasize the importance of personal hygiene and facial cleanliness.
- E (Environmental Improvement): Significantly improving access to clean water and sanitation, which effectively eliminates the environmental conditions that allow flies to thrive and transmit the bacteria.
This multisectoral coordination—linking health professionals, civil engineers, educators, and community leaders—was the engine of Algeria’s success.
Official Voices: Recognizing the Milestone
The validation of Algeria’s achievement has been met with widespread praise from international health leaders, who view the event as a beacon of hope for the global health community.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the nation’s persistence: "Algeria’s elimination of trachoma is a historic triumph that connects the past, present, and future of public health, and is rooted in a century-long commitment. This milestone proves that with sustained political will and on-the-ground leadership, we can eliminate neglected tropical diseases and build a healthier, more resilient future for all."
Dr. Mohamed Janabi, WHO Regional Director for Africa, emphasized the human impact: "Trachoma devastates individuals and communities, causing painful economic and livelihood loss. This achievement transforms the health and well-being of children, women, and entire families. It demonstrates that eliminating neglected tropical diseases is entirely possible with consistent, coordinated effort."
Professor Mohamed Seddik Ait Messaoudene, Algeria’s Minister of Health, reflected on the collective nature of the victory: "This success was made possible through the mobilization of all stakeholders, the dedication of health professionals, the support of key partners, and the technical assistance of the WHO. It attests to our country’s capacity to meet the most rigorous public health standards—standards grounded in prevention and equitable access to care."
Looking Ahead: Surveillance and Sustainability
While the WHO has validated the elimination, the work is far from over. Elimination does not mean the total eradication of the bacterium; rather, it means the disease is no longer a public health threat. To ensure this remains the case, the WHO is working closely with Algerian health authorities to maintain robust surveillance systems.
The goal is to monitor previously endemic populations to ensure there is no resurgence. Algeria’s infrastructure—including its well-functioning school health system, centralized health information databases, and widespread access to specialized eye care—provides a durable foundation for this post-validation phase.
Implications for Global Public Health
Algeria’s victory holds profound implications for the global fight against "Neglected Tropical Diseases" (NTDs). NTDs represent a group of 21 conditions that inflict devastating health and economic burdens on more than one billion people worldwide, predominantly in impoverished regions.
By eliminating trachoma, Algeria becomes the 62nd country globally and the 23rd in the WHO African Region to have successfully eradicated at least one neglected tropical disease. This is a vital step toward the WHO’s 2021–2030 road map for NTDs, which sets ambitious targets for the control and eventual elimination of these conditions.
The lesson from Algeria is clear: diseases that have plagued humanity for millennia are not inevitable. Through the integration of standardized surgical care, massive public awareness, and the improvement of fundamental living conditions—water and sanitation—nations can dismantle the structures that allow infectious diseases to thrive. Algeria has provided the world with a roadmap, proving that with patience, political courage, and scientific rigor, the vision of a world free from the threat of preventable blindness is well within our reach.
About the Author
